These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6119718)

  • 1. Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study.
    Galdi J; Rieder RO; Silber D; Bonato RR
    Psychol Med; 1981 Nov; 11(4):713-28. PubMed ID: 6119718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation trial on the efficacy of neuroleptics on the outcome of schizophrenia].
    Dollfus S; Petit M
    Encephale; 1991; 17(4):247-53. PubMed ID: 1683625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetry of neuroleptic-induced rigidity: development of quantitative methods and clinical correlates.
    Caligiuri MP; Bracha HS; Lohr JB
    Psychiatry Res; 1989 Dec; 30(3):275-84. PubMed ID: 2575771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Never treated schizophrenic patients have no abnormal movements such as tardive dyskinesia].
    Chorfi M; Moussaoui D
    Encephale; 1985; 11(6):263-5. PubMed ID: 2869939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics.
    Prosser ES; Csernansky JG; Kaplan J; Thiemann S; Becker TJ; Hollister LE
    J Nerv Ment Dis; 1987 Feb; 175(2):100-5. PubMed ID: 2879880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of late-life schizophrenia with neuroleptics.
    Jeste DV; Lacro JP; Gilbert PL; Kline J; Kline N
    Schizophr Bull; 1993; 19(4):817-30. PubMed ID: 7905663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prevalence of schizophrenia spectrum disorders in relatives of neuroleptic-nonresponsive schizophrenic patients.
    Joober R; Rouleau GA; Lal S; Bloom D; Lalonde P; Labelle A; Benkelfat C
    Schizophr Res; 2005 Sep; 77(1):35-41. PubMed ID: 16005383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics.
    Juckel G; Schlagenhauf F; Koslowski M; Filonov D; Wüstenberg T; Villringer A; Knutson B; Kienast T; Gallinat J; Wrase J; Heinz A
    Psychopharmacology (Berl); 2006 Aug; 187(2):222-8. PubMed ID: 16721614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Principles of chemotherapy of paranoid schizophrenia].
    Vanelle JM; Loloum T
    Encephale; 1991; 17(4):235-40. PubMed ID: 1683623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug abuse experience and neuroleptic prescriptions at the onset of schizophrenia].
    Lisoprawski A
    Sem Hop; 1983 Jun; 59(25):1925-7. PubMed ID: 6136096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alterations of gait parameters under external cueing in schizophrenic patients: a switch study].
    Putzhammer A; Perfahl M; Pfeiff L; Broll K; Hess L; Ibach B
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S164-6. PubMed ID: 15570541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics.
    Spohn HE; Coyne L
    Brain Cogn; 1993 Sep; 23(1):28-39. PubMed ID: 8105820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
    Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
    Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
    Meltzer HY; Sommers AA; Luchins DJ
    J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis.
    Salokangas RK
    Schizophr Res; 1995 Jul; 16(1):7-16. PubMed ID: 7547647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic-resistant schizophrenics.
    Murray JB
    J Psychol; 1989 Jan; 123(1):69-78. PubMed ID: 2564435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.